Fred Alger Management, LLC Glaukos Corp Transaction History

Fred Alger Management, LLC

$19.7 Billion
Q4 2024

A detailed history of Fred Alger Management, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Fred Alger Management, LLC holds 764,958 shares of GKOS stock, worth $123 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

764,958

Previous 1,076,974 28.97%

Holding current value

$123 Million

Previous $140 Million 18.25%

% of portfolio

0.58%

Previous 0.71%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$126.42 - $152.67 $39.4 Million - $47.6 Million	-312,016 Reduced 28.97%	764,958 $115 Million
Q3 2024 Nov 14, 2024	SELL	$113.62 - $135.39 $22.9 Million - $27.3 Million	-201,749 Reduced 15.78%	1,076,974 $140 Million
Q2 2024 Aug 14, 2024	BUY	$89.48 - $118.35 $4.23 Million - $5.6 Million	47,308 Added 3.84%	1,278,723 $151 Million
Q1 2024 May 15, 2024	SELL	$76.4 - $96.33 $31.6 Million - $39.8 Million	-413,666 Reduced 25.15%	1,231,415 $116 Million
Q4 2023 Feb 14, 2024	SELL	$59.53 - $85.11 $8.07 Million - $11.5 Million	-135,609 Reduced 7.62%	1,645,081 $131 Million
Q3 2023 Nov 14, 2023	BUY	$69.23 - $79.09 $10.4 Million - $11.9 Million	150,102 Added 9.21%	1,780,690 $134 Million
Q2 2023 Aug 14, 2023	BUY	$45.44 - $71.21 $4.99 Million - $7.82 Million	109,801 Added 7.22%	1,630,588 $116 Million
Q1 2023 May 15, 2023	BUY	$43.88 - $52.48 $8.51 Million - $10.2 Million	194,028 Added 14.62%	1,520,787 $76.2 Million
Q4 2022 Feb 14, 2023	SELL	$40.82 - $57.75 $3.08 Million - $4.35 Million	-75,351 Reduced 5.37%	1,326,759 $58 Million
Q3 2022 Nov 14, 2022	BUY	$46.84 - $58.49 $16.8 Million - $21 Million	358,360 Added 34.33%	1,402,110 $74.6 Million
Q2 2022 Aug 15, 2022	BUY	$34.86 - $63.77 $1.39 Million - $2.55 Million	39,959 Added 3.98%	1,043,750 $47.4 Million
Q1 2022 May 16, 2022	BUY	$44.33 - $57.82 $1.69 Million - $2.2 Million	38,088 Added 3.94%	1,003,791 $58 Million
Q4 2021 Feb 14, 2022	BUY	$40.27 - $56.99 $14.1 Million - $19.9 Million	348,954 Added 56.58%	965,703 $42.9 Million
Q3 2021 Nov 15, 2021	SELL	$47.43 - $84.23 $4.36 Million - $7.74 Million	-91,938 Reduced 12.97%	616,749 $29.7 Million
Q2 2021 Aug 16, 2021	BUY	$73.06 - $97.7 $639,859 - $855,656	8,758 Added 1.25%	708,687 $60.1 Million
Q1 2021 May 17, 2021	BUY	$70.43 - $97.42 $17.7 Million - $24.5 Million	251,678 Added 56.15%	699,929 $58.7 Million
Q4 2020 Feb 16, 2021	SELL	$48.9 - $75.26 $16.7 Million - $25.6 Million	-340,536 Reduced 43.17%	448,251 $33.7 Million
Q3 2020 Nov 13, 2020	SELL	$37.23 - $50.97 $14.9 Million - $20.4 Million	-399,651 Reduced 33.63%	788,787 $39.1 Million
Q2 2020 Aug 14, 2020	SELL	$28.78 - $46.83 $48.1 Million - $78.3 Million	-1,671,734 Reduced 58.45%	1,188,438 $45.7 Million
Q1 2020 May 15, 2020	BUY	$25.53 - $70.14 $15.9 Million - $43.8 Million	624,749 Added 27.95%	2,860,172 $88.3 Million
Q4 2019 Feb 14, 2020	BUY	$54.18 - $65.64 $7.22 Million - $8.75 Million	133,232 Added 6.34%	2,235,423 $122 Million
Q3 2019 Nov 14, 2019	BUY	$58.58 - $83.91 $66.5 Million - $95.2 Million	1,134,638 Added 117.27%	2,102,191 $131 Million
Q2 2019 Aug 14, 2019	BUY	$63.59 - $78.71 $15.8 Million - $19.6 Million	248,679 Added 34.59%	967,553 $73 Million
Q1 2019 May 14, 2019	BUY	$50.75 - $80.54 $30.8 Million - $48.8 Million	606,227 Added 538.17%	718,874 $56.3 Million
Q4 2018 Feb 14, 2019	SELL	$52.18 - $67.93 $2.98 Million - $3.88 Million	-57,158 Reduced 33.66%	112,647 $6.33 Million
Q3 2018 Nov 14, 2018	BUY	$38.13 - $68.37 $3.75 Million - $6.72 Million	98,225 Added 137.22%	169,805 $11 Million
Q2 2018 Jul 19, 2018	BUY	$27.62 - $44.51 $1.98 Million - $3.19 Million	71,580 New	71,580 $2.91 Million

Others Institutions Holding GKOS

# of Institutions

354

Shares Held

50M

Call Options Held

282K

Put Options Held

401K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.64B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account

Fred Alger Management, LLC Glaukos Corp Transaction History